Westlake Village BioPartners
28
76M
16
4.67
3
0.43
- Areas of investment
Summary
Westlake Village BioPartners appeared to be the VC, which was created in 2018. The venture was found in North America in United States. The main department of described VC is located in the Westlake Village.
The common things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in 2-6 investment rounds annually. The important activity for fund was in 2019.
The fund was created by Beth Seidenberg.
Among the most popular portfolio startups of the fund, we may highlight ArsenalBio. Among the most popular fund investment industries, there are Biotechnology, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Westlake Village BioPartners, startups are often financed by Lilly Asia Ventures, Ping An Ventures, Penn Medicine Co-Investment Fund. The meaningful sponsors for the fund in investment in the same round are Vida Ventures, University of California, UCSF Foundation Investment Company.
Investments analytics
Analytics
- Total investments
- 28
- Lead investments
- 3
- Rounds per year
- 4.67
- Follow on index
- 0.43
- Investments by industry
- Biotechnology (17)
- Health Care (16)
- Therapeutics (8)
- Medical (6)
- Life Science (6) Show 6 more
- Investments by region
-
- United States (25)
- United Kingdom (2)
- Peak activity year
- 2022
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 4
- Avg. valuation at time of investment
- 3M
- Group Appearance index
- 0.96
- Strategy success index
- 0.30
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Electra Therapeutics | 16 Feb 2022 | Biotechnology, Health Care, Medical | Early Stage Venture | 84M | United States, California, San Francisco |
| Latigo Biotherapeutics | 14 Feb 2024 | Early Stage Venture | 135M | ||
| Shotlst | 01 Jul 2012 | Software, Information Technology, Messaging, Photography, Task Management, Industrial | Seed | 23K | Ontario, Old Toronto, Canada |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.